[1]
Lavoie JM,Kollmannsberger CK, Current Management of Disseminated Germ Cell Tumors. The Urologic clinics of North America. 2019 Aug; [PubMed PMID: 31277732]
[2]
Kong J,Yi L,Xiong Y,Huang Y,Yang D,Yan X,Shen B,Duan Y,Zhu X, The discovery and development of microbial bleomycin analogues. Applied microbiology and biotechnology. 2018 Aug; [PubMed PMID: 29876605]
[4]
Bagheri R,Noori M,Rajayi M,Attaran D,Mohammad Hashem Asna Ashari A,Mohammadzadeh Lari S,Basiri R,Rezaeetalab F,Afghani R,Salehi M, The effect of iodopovidone versus bleomycin in chemical pleurodesis. Asian cardiovascular [PubMed PMID: 29792037]
[5]
Petering DH,Byrnes RW,Antholine WE, The role of redox-active metals in the mechanism of action of bleomycin. Chemico-biological interactions. 1990; [PubMed PMID: 1690086]
[6]
Murray V,Chen JK,Chung LH, The Interaction of the Metallo-Glycopeptide Anti-Tumour Drug Bleomycin with DNA. International journal of molecular sciences. 2018 May 4; [PubMed PMID: 29734689]
[7]
Dorr RT, Bleomycin pharmacology: mechanism of action and resistance, and clinical pharmacokinetics. Seminars in oncology. 1992 Apr; [PubMed PMID: 1384141]
[8]
Broughton A,Strong JE,Holoye PY,Bedrossian CW, Clinical pharmacology of bleomycin following intravenous infusion as determined by radioimmunoassay. Cancer. 1977 Dec; [PubMed PMID: 73408]
[9]
Hall SW,Strong JE,Broughton A,Frazier ML,Benjamin RS, Bleomycin clinical pharmacology by radioimmunoassay. Cancer chemotherapy and pharmacology. 1982; [PubMed PMID: 6183016]
[10]
Kato S,Inui N,Hakamata A,Suzuki Y,Enomoto N,Fujisawa T,Nakamura Y,Watanabe H,Suda T, Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis. Respiratory research. 2018 Jun 26; [PubMed PMID: 29940932]
[11]
O'Sullivan JM,Huddart RA,Norman AR,Nicholls J,Dearnaley DP,Horwich A, Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours. Annals of oncology : official journal of the European Society for Medical Oncology. 2003 Jan; [PubMed PMID: 12488299]
[12]
Shippee BM,Bates JS,Richards KL, The role of screening and monitoring for bleomycin pulmonary toxicity. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2016 Apr; [PubMed PMID: 25736276]
[13]
Watson RA,De La Peña H,Tsakok MT,Joseph J,Stoneham S,Shamash J,Joffe J,Mazhar D,Traill Z,Ho LP,Brand S,Protheroe AS, Development of a best-practice clinical guideline for the use of bleomycin in the treatment of germ cell tumours in the UK. British journal of cancer. 2018 Oct; [PubMed PMID: 30356125]